| Radioiodine refractory differentiated thyroid cancer Y Jin, D Van Nostrand, L Cheng, M Liu, L Chen Critical reviews in oncology/hematology 125, 111-120, 2018 | 82 | 2018 |
| HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E L Cheng, Y Jin, M Liu, M Ruan, L Chen Oncotarget 8 (12), 19843, 2017 | 53 | 2017 |
| MAPK inhibitors enhance HDAC inhibitor-induced redifferentiation in papillary thyroid cancer cells harboring BRAFV600E: an in vitro study H Fu, L Cheng, Y Jin, L Cheng, M Liu, L Chen Molecular Therapy-Oncolytics 12, 235-245, 2019 | 38 | 2019 |
| Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin M Liu, L Cheng, Y Jin, M Ruan, S Sheng, L Chen Scientific Reports 8 (1), 4352, 2018 | 30 | 2018 |
| Clinicopathological Features Predict Outcomes in Patients with Radioiodine‐Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real‐World Study L Cheng, H Fu, Y Jin, R Sa, L Chen The Oncologist 25 (4), e668, 2020 | 25 | 2020 |
| Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global … H Fu, L Cheng, R Sa, Y Jin, L Chen Journal of Cellular and Molecular Medicine 24 (6), 3336-3345, 2020 | 25 | 2020 |
| Radioiodine uptake and thyroglobulin-guided radioiodine remnant ablation in patients with differentiated thyroid cancer: a prospective, randomized, open-label, controlled trial Y Jin, M Ruan, L Cheng, H Fu, M Liu, S Sheng, L Chen Thyroid 29 (1), 101-110, 2019 | 25 | 2019 |
| Thyrotoxicosis with concomitant thyroid cancer H Fu, L Cheng, Y Jin, L Chen Endocrine-related cancer 26 (7), R395-R413, 2019 | 23 | 2019 |
| Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics Y Jin, M Liu, R Sa, H Fu, L Cheng, L Chen Cancer Letters 469, 35-53, 2020 | 19 | 2020 |
| Poorly differentiated thyroid carcinoma: a clinician’s perspective J Tong, M Ruan, Y Jin, H Fu, L Cheng, Q Luo, Z Liu, Z Lv, L Chen European Thyroid Journal 11 (2), 2022 | 15 | 2022 |
| Unexplained hyperthyroglobulinemia in differentiated thyroid cancer patients as an indication for radioiodine adjuvant therapy: A prospective multicenter study L Cheng, R Sa, Q Luo, H Fu, Y Jin, L Tang, Y Yang, C Yu, L Chen Journal of Nuclear Medicine 62 (1), 62-68, 2021 | 12 | 2021 |
| Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18. 2 W Wei, D Zhang, Y Zhang, L Li, Y Jin, S An, H Zhao, C Wang, Y Huang, ... Molecular Therapy-Oncolytics 27, 305-314, 2022 | 10 | 2022 |
| Next-generation molecular imaging of thyroid cancer Y Jin, B Liu, MH Younis, G Huang, J Liu, W Cai, W Wei Cancers 13 (13), 3188, 2021 | 9 | 2021 |
| Updated review of nuclear molecular imaging of thyroid cancers H Fu, R Sa, L Cheng, Y Jin, X Qiu, M Liu, L Chen Endocrine Practice 27 (5), 494-502, 2021 | 9 | 2021 |
| Distinguishing patients with distant metastatic differentiated thyroid cancer who biochemically benefit from next radioiodine treatment R Sa, L Cheng, Y Jin, H Fu, Y Shen, L Chen Frontiers in Endocrinology 11, 587315, 2020 | 8 | 2020 |
| Initial therapy of advanced anaplastic thyroid cancer via targeting VEGFR-2: a case report L Cheng, Q Jiao, Y Jin, H Fu, H Zhang, L Chen OncoTargets and therapy, 10495-10500, 2019 | 8 | 2019 |
| False-positive uptake of 131I due to tubal ligation in a patient with papillary thyroid cancer J Tong, Y Jin, M Liu, Z Lv, L Chen Clinical Nuclear Medicine 43 (5), 375-376, 2018 | 3 | 2018 |
| ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer Y Jin, X Qiu, Z He, JY Wang, R Sa, L Chen Frontiers in Genetics 13, 966365, 2022 | 2 | 2022 |
| Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study L Cheng, R Sa, Q Luo, H Fu, Y Jin, L Tang, Y Yang, C Yu, L Chen Journal of Nuclear Medicine, 2020 | 1 | 2020 |
| Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report Y Jin, M Liu, L Cheng, L Chen BMC cancer 17, 1-3, 2017 | 1 | 2017 |
